National Prescribing Trends and Cost Analysis of Antidepressants, Anxiolytics, and Hypnotics in England, 2010–2023
Overall trends demonstrate a more than doubling of antidepressant prescribing over the period 2010-2023, with similar volume reduction in anxiolytics/hypnotics over the same period. Such real world data facilitate the development of policy influencing insights for psychotropic prescribing management now and in coming years.
Authors
- Joseph Ingram
- David Taylor (ORCID: https://orcid.org/0000-0002-2557-1710)
- Jeff Levy
- Mike Stedman (ORCID: https://orcid.org/0000-0002-0491-7823)
- Adrian Hugh Heald (ORCID: https://orcid.org/0000-0002-9537-4050)
- Mark Davies (ORCID: https://orcid.org/0000-0001-9315-9130)
Institutions
- Greater Manchester Mental Health NHS Foundation Trust (GB)
- University of Manchester (GB)
- Salford Royal Hospital (GB)
- Psychiatry Research Trust (GB)
Publication Details
- Journal
- Human Psychopharmacology Clinical and Experimental
- Published
- 2025-08-18
- DOI
- https://doi.org/10.1002/hup.70011
- Citations
- 1
- Primary Topic
- Mental Health Treatment and Access
- Type
- article
- Field-Weighted Citation Impact
- 2.44